Navigation Links
Stem Cell Industry Expert Praises, Encourages Continued Progress on Legislation to Promote Benefits of Cord Blood
Date:7/6/2009

OLDSMAR, Fla., July 6 /PRNewswire-FirstCall/ -- Mercedes Walton, CEO of Cryo-Cell International, one of the largest and most established family cord blood banks, is praising legislative progress to date and encouraging continued momentum for existing bills through the second half of the year. H.R. 1718, the "Family Cord Blood Banking Act," and H.R. 2107, the "Cord Blood Education and Awareness Act of 2009" would continue to build on the progress from the first half of the year to enable and promote the continued research, public awareness and tax benefits related to storing and using cord blood, all of which provide great benefit to families across America.

In early March, President Obama paved the way for progress by signing an executive order to remove barriers of responsible stem cell research. Later that month, U.S. Congressman Ronald Kline sponsored H.R. 1718, a proposed bill to provide significant tax benefits for the costs associated with umbilical cord blood banking. H.R. 1718 would amend an existing tax law in order to add these services to a list of qualified medical expenses that may be paid for with pre-tax dollars, or be deducted from taxable income.

The promise of continued progress came in late April, when Congresswoman Jackie Speier introduced H.R. 2107, the "Cord Blood Education and Awareness Act of 2009."

The proposed legislation, which was referred to committee in early June, directs the Secretary of Health and Human Services to conduct a public education campaign on umbilical cord blood stem cells. The campaign would be aimed to develop methods to educate expectant parents about their options for banking or donating their child's cord blood.

H.R. 2107 also seeks to bring healthcare professionals up-to-date on the value of cord blood banking and would make grants available to reach crucial segments of the population, such as minority communities and families with a genetic history of treatable diseases.

"This year's encouraging volume of activity is testament to the growing acknowledgement of the benefits of stem cells, including non-controversial sources such as umbilical cord blood," says Cryo-Cell CEO Mercedes Walton. "As we reach the midpoint in the year it's a great time to reflect on the important progress that has been made, and to ensure that we maintain the positive momentum toward change that will benefit America's families today and for decades to come."

"We are encouraged and grateful on behalf of the families who may soon be able to more readily learn of the potential life-saving benefits of banking their baby's cord blood, and have the opportunity to realize tax benefits as they would other medical costs," said Walton. "Every day, all of us at Cryo-Cell are motivated by the stories of families who have been touched by the miracle of stem cells, and by the rapid progress being made by the scientific community," adds Walton.

Currently, stem cells from cord blood treat more than 75 such conditions, including sickle cell disease, several types of acute and chronic leukemias, Non-Hodgkin's lymphoma, and Hodgkin's disease. Emerging science shows great promise for potential treatments including spinal cord injury, heart disease, breast cancer, stroke, diabetes, Parkinson's disease, Alzheimer's disease and many more.

A pioneer in the non-controversial stem cell arena, Cryo-Cell has served over 175,000 clients worldwide and led the cord blood banking industry with the successful establishment of a state-of-the-art Good Manufacturing Practice/Good Tissue Practice (cGMP/cGTP) laboratory processing facility well ahead of emerging regulation and competition.

About Cryo-Cell International, Inc. (OTC Bulletin Board: CCEL.OB)

Based in Oldsmar, Florida, with over 175,000 clients worldwide, Cryo-Cell is one of the largest and most established family cord blood banks. ISO 9001:2000 certified and accredited by the AABB, Cryo-Cell operates in a state-of-the-art Good Manufacturing Practice and Good Tissue Practice (cGMP/cGTP)-compliant facility. Cryo-Cell is a publicly traded company. OTC Bulletin Board Symbol: CCEL. For more information, please call 1-800-STOR-CELL (1-800-786-7235) or visit www.cryo-cell.com.


'/>"/>
SOURCE Cryo-Cell International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Health Integrated Hosts Industry Collaborative Focused on the Patient-Centered Medical Home (PCMH)
2. Its Time to Clean Up This Mess: Texas Surgeon Points Out Numerous Flaws in American Health Care Industry
3. ISPA Releases 2009 U.S. Spa Industry Statistics
4. Pistachio Industry Looks Toward a Promising 2009 Crop Year
5. CareFusion Launches New Brand, Establishing Itself as an Industry Leader in Helping Hospitals Improve Patient Care and Safety
6. Industry Leader Announces Next Generation of Patient Flow Automation
7. The Meetings Industry...Stirred But Not Shaken by Current Economic Setbacks - Patriot Meetings Announces Their 360 Degree Program that Ensures Successful Meetings
8. Food Ingredients Industry Leaders Applaud the Launch of Health ingredients South America
9. Global Autoimmune Disease Therapeutics Market to Reach $50 Billion by 2015, According to a New Report by Global Industry Analysts
10. Renowned Medical Tourism Industry Expert and Author Josef D. Woodman Joins Satori World Medical's Strategic Advisory Board
11. TAHU Takes on New Leadership During Vital Time in Health Insurance Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... PA (PRWEB) , ... February 17, 2017 , ... Butler ... about the Stannah Stairlift and other Butler products. Ken was impressed with the ... and agreed to endorse the product on his show. This endorsement by Ken ...
(Date:2/18/2017)... ... February 18, 2017 , ... A ... information and contact points to easily connect elderly veterans of America's armed forces ... elder-care funding. It also conveys material on this year's increase in the Veterans ...
(Date:2/17/2017)... ... February 17, 2017 , ... Wells ... the electronic prescribing of controlled and non-controlled substances plus the ability to manage ... in the United States now accept electronic prescriptions, according to the Office of ...
(Date:2/17/2017)... ... February 17, 2017 , ... Corrective Action & Preventive ... FDAnews Webinar**, Feb. 23, 2017 — 1:30 p.m. – 3:00 p.m. ET, ... and preventive action (PA)? , The methods share techniques and tools but they ...
(Date:2/17/2017)... ... February 17, 2017 , ... MAP Revenue ... that Karen Pilley has been promoted to Chief Executive Officer. , The ... paradigm – a shift that demands the transition from pay-for-service to pay-for-performance models. ...
Breaking Medicine News(10 mins):
(Date:2/18/2017)... and Markets has announced the addition of the "Contraceptives - Global ... ... US, Canada , Japan , ... America , and Rest of World. Annual estimates and forecasts are ... is provided for these markets. Market data and analytics are derived from ...
(Date:2/17/2017)... According to a new market research report ... Application (Cleanroom Monitoring, Contamination Monitoring of Liquids), and End User (Healthcare ... the market is expected to reach USD 330.6 Million by 2021 ... from 2016 to 2021. Continue Reading ... ...
(Date:2/17/2017)... Research and Markets has announced the addition of ... to their offering. ... provides separate comprehensive analytics for the US, Canada , ... Asia-Pacific , and Rest of World. Annual estimates and forecasts are ... is provided for these markets. Market data and analytics are derived from ...
Breaking Medicine Technology: